| 1 |
Drugs used for the treatment of cerebral and disseminated infections caused by free-living amoebae |
|
| | Alexandre Taravaud,Zineb Fechtali-Moute,Philippe M. Loiseau,Sébastien Pomel | | | Clinical and Translational Science. 2021; 14(3): 791 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Fulminant acanthamoebic meningoencephalitis in immunocompetent patients: an uncommon entity |
|
| | Lokesh Suresh Nehete,Anil Kumar,Pooja Chavali,Prabhuraj A. R.,Bhagavatula Indira Devi | | | British Journal of Neurosurgery. 2018; : 1 | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
In vivo CNS infection model of Acanthamoeba genotype T4: the early stages of infection lack presence of host inflammatory response and are a slow and contact-dependent process |
|
| | Maritza Omaña-Molina,Dolores Hernandez-Martinez,Raquel Sanchez-Rocha,Ulises Cardenas-Lemus,Citlaltepetl Salinas-Lara,Adolfo Rene Mendez-Cruz,Laura Colin-Barenque,Patricia Aley-Medina,Jesus Espinosa-Villanueva,Leticia Moreno-Fierros,Jacob Lorenzo-Morales | | | Parasitology Research. 2016; | | | [Pubmed] [Google Scholar] [DOI] | |
|
